22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
Where’s the beef? In Arkansas federal court, where the Tofurky Company challenged a new state law t...
Read More >
The legal rules applicable to the “gig” economy continue to evolve. In the past year, there have b...
Read More >
The National Labor Relations Board (NLRB) issued two decisions on December 17, 2019, that reversed p...
Read More >
As the coronavirus pandemic’s devastating impacts continue to evolve, governments at all levels (lo...
Read More >
Bad Choices For 401(k) Plan Sponsors That Often Lead To Bad Results - It's not about luck. My gran...
Read More >
Employers sometimes include fixed terms of employment in their employment agreement. Sometimes a fix...
Read More >